These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31693279)

  • 1. Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.
    Miceli F; Presta V; Citoni B; Canichella F; Figliuzzi I; Ferrucci A; Volpe M; Tocci G
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1863-1871. PubMed ID: 31693279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: A cross-sectional study.
    Bult MM; van de Ree TF; Wind AM; Hurley KM; van de Ree MA
    J Clin Hypertens (Greenwich); 2024 Aug; 26(8):977-985. PubMed ID: 38963706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes.
    Jiang X; Quan X; Yang J; Zhou X; Hu A; Zhang Y
    J Clin Hypertens (Greenwich); 2019 Mar; 21(3):372-378. PubMed ID: 30706989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
    J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
    Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
    Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal.
    Rautaharju PM; Soliman EZ
    J Electrocardiol; 2014; 47(5):649-54. PubMed ID: 25012077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population.
    Ishikawa J; Ishikawa S; Kabutoya T; Gotoh T; Kayaba K; Schwartz JE; Pickering TG; Shimada K; Kario K;
    Hypertension; 2009 Jan; 53(1):28-34. PubMed ID: 19015402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.
    Hawkins NM; Wang D; McMurray JJ; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG;
    Heart; 2007 Jan; 93(1):59-64. PubMed ID: 16952975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
    Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B;
    Ann Intern Med; 2007 Sep; 147(5):311-9. PubMed ID: 17785486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study.
    Kannel WB; Abbott RD
    Am Heart J; 1986 Feb; 111(2):391-7. PubMed ID: 2936230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.
    Cramariuc D; Gerdts E
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):915-26. PubMed ID: 27159191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex, gender, and subclinical hypertensiveorgan damage-heart.
    Cuspidi C; Gherbesi E; Sala C; Tadic M
    J Hum Hypertens; 2023 Aug; 37(8):626-633. PubMed ID: 36030347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.